Table 1:

Response assessment classifications of 50 MR imaging time points for 3 tumor-management strategiesa

Clinical CPSemiautomated CPVolume (25/50)Volume (40/65)
PRSDPDPRSDPDPRSDPDPRSDPD
Clinical CP
 PR000000000
 SD22514223161328
 PD027027036
 Concordance64%60%76%
Semiautomated CP
 PR200110
 SD02070252
 PD05160912
 Concordance76%76%
Volume
 PR110
 SD0250
 PD0914
 Concordance80%
  • a Two different tumor-response criteria were applied to the volume data (25/50 uses the same criteria as used for CP-response determinations, 40/65 denotes PR as >65% decrease from baseline and PD as >40% increase from the prior lowest tumor size). Unless otherwise noted, values represent the number of MR imaging time points.